Meta-Analysis of Ado-Trastuzumab Emtansine in Patients with HER2- Positive Advanced Metastatic Breast Cancer

Journal Title: Journal of Medical Science And clinical Research - Year 2014, Vol 2, Issue 5

Abstract

This study identifies and reviews randomized evidence to determine the effectiveness and safety of AdoTrastuzumab Emtansine in patients with advanced metastatic breast cancer. Cochrane Breast Cancer Group specialized register; Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CINAHL and WHO International Clinical Registry platform were searched using the appropriate search strategy. Either recurrent or newly diagnosed women with Metastatic Breast Cancer were included. Four randomized controlled trials with 1,350 patients estimated overall survival as 64.7% in TDM1 group versus 51.8% in non TDM1 group. EMILIA study reported improved progression free survival (PFS) by 5.8 months, Overall Response Rate (ORR) as 43.6% in TDM1 group vs. 30.8% control group and low adverse events by 16.2%. Hurvitz study reported PFS 5 months longer in T-DM1 group than in control group with stratified HR of 0.59;(95% CI, 0.36 to 0.97), ORR as 64.2% (TDM 1 group) vs. 58% in control group, low adverse events by 45.2%. Single arm phase II study BURRIS & KROP reported PFS as 4.6 and 6.9 months respectively, ORR 25.9% and 34.5% respectively, and adverse events as 15.2% and 55.4% respectively. Consistent favorable outcomes with the Ado-Trastuzumab Emtansine indicate its considerable efficacy and safety in the treatment of advanced metastatic breast cancer and promising drug in combating mortality with breast cancer.

Authors and Affiliations

Dr Rajat Rana

Keywords

Related Articles

Maternal and Fetal Outcome in Fibroid Complicating Pregnancy in a Tertiary Care Centre

Background: Fibroid is the most common beningntumour of the uterus. Their incidence in pregnancy is between 1-2%.Complication can occur in 10-40% in the presence of fibroids. Aim: The aim our study is to assess the mater...

Co-Morbidity of Pulmonary Tuberculosis and Diabetes MellitusA Prospective Analysis

Several studies have evaluated the relationship between diabetes mellitus (DM) and tuberculosis (TB), but the nature of this relationship is not fully understood. TB incidence may be influenced by immune suppression from...

Study of Clinical Symptoms and Etiology of Hyponatremia in Elderly in Intensive Care Unit

Hyponatremia is a common electrolyte disturbances encountered in intensive care units especially in the elderly and contributes to substantial morbidity and mortality. It remains a common yet neglected area of clinical p...

A Prospective Study Comparing Oxaliplatin & 5-Fu with Gemcitabine & Cisplatin in Advanced Stage Carcinoma Gall Bladder

Background: Overall incidence of Gallbladder (GB) malignancy is rare but it is the most common primary hepatobiliary carcinoma. Its incidence is highest in India and median survival is less than 6 months. Different chemo...

Suicidal Death in Carbolic Acid Poisoning in Geriatric Age Group- A Rare Case Report

Deaths due to poisoning are not uncommon in India. Cases of carbolic acid poisoning were more frequent in the past than today. Approximately 55% of those reported have terminated fatally. Ingestion of carbolic acid for s...

Download PDF file
  • EP ID EP205926
  • DOI -
  • Views 97
  • Downloads 0

How To Cite

Dr Rajat Rana (2014). Meta-Analysis of Ado-Trastuzumab Emtansine in Patients with HER2- Positive Advanced Metastatic Breast Cancer. Journal of Medical Science And clinical Research, 2(5), 1222-1234. https://europub.co.uk/articles/-A-205926